MX2010002680A - Uso de derivados de purina para la manufactura de un medicamento. - Google Patents
Uso de derivados de purina para la manufactura de un medicamento.Info
- Publication number
- MX2010002680A MX2010002680A MX2010002680A MX2010002680A MX2010002680A MX 2010002680 A MX2010002680 A MX 2010002680A MX 2010002680 A MX2010002680 A MX 2010002680A MX 2010002680 A MX2010002680 A MX 2010002680A MX 2010002680 A MX2010002680 A MX 2010002680A
- Authority
- MX
- Mexico
- Prior art keywords
- medicament
- manufacture
- purine derivatives
- apoptosis
- purine
- Prior art date
Links
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 230000001575 pathological effect Effects 0.000 abstract 2
- 230000032823 cell division Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0706390A FR2920776B1 (fr) | 2007-09-12 | 2007-09-12 | Utilisation de derives de purine pour la fabrication d'un medicament |
| PCT/FR2008/001278 WO2009068761A2 (fr) | 2007-09-12 | 2008-09-12 | Utilisation de derives de purine pour la fabrication d'un medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010002680A true MX2010002680A (es) | 2010-08-26 |
Family
ID=39382006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010002680A MX2010002680A (es) | 2007-09-12 | 2008-09-12 | Uso de derivados de purina para la manufactura de un medicamento. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8431583B2 (enExample) |
| EP (1) | EP2187889B1 (enExample) |
| JP (1) | JP5485893B2 (enExample) |
| KR (1) | KR20100075908A (enExample) |
| CN (1) | CN101918000B (enExample) |
| BR (1) | BRPI0816810A2 (enExample) |
| CA (1) | CA2699590A1 (enExample) |
| DK (1) | DK2187889T3 (enExample) |
| ES (1) | ES2444419T3 (enExample) |
| FR (1) | FR2920776B1 (enExample) |
| MX (1) | MX2010002680A (enExample) |
| RU (1) | RU2500400C2 (enExample) |
| WO (1) | WO2009068761A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2920776B1 (fr) | 2007-09-12 | 2012-09-28 | Centre Nat Rech Scient | Utilisation de derives de purine pour la fabrication d'un medicament |
| WO2010103473A1 (en) * | 2009-03-10 | 2010-09-16 | Chu De Brest | Method of treatment of polycystic diseases and chronic lymphocytic leukemia |
| WO2013130461A1 (en) * | 2012-02-29 | 2013-09-06 | The Scripps Research Institute | Wee1 degradation inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
| US6627633B2 (en) * | 1999-03-17 | 2003-09-30 | Albany Molecular Research, Inc. | 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents |
| US6969720B2 (en) * | 1999-03-17 | 2005-11-29 | Amr Technology, Inc. | Biaryl substituted purine derivatives as potent antiproliferative agents |
| DE60205376T2 (de) * | 2001-06-27 | 2006-04-06 | Cyclacel Ltd. | 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten |
| US6812232B2 (en) * | 2001-09-11 | 2004-11-02 | Amr Technology, Inc. | Heterocycle substituted purine derivatives as potent antiproliferative agents |
| US6667311B2 (en) * | 2001-09-11 | 2003-12-23 | Albany Molecular Research, Inc. | Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents |
| GB0315259D0 (en) | 2003-06-30 | 2003-08-06 | Cyclacel Ltd | Use |
| AU2004264419B2 (en) * | 2003-08-15 | 2009-01-15 | Irm Llc | 6-substituted anilino purines as RTK inhibitors |
| FR2920776B1 (fr) | 2007-09-12 | 2012-09-28 | Centre Nat Rech Scient | Utilisation de derives de purine pour la fabrication d'un medicament |
-
2007
- 2007-09-12 FR FR0706390A patent/FR2920776B1/fr active Active
-
2008
- 2008-09-12 KR KR1020107007886A patent/KR20100075908A/ko not_active Ceased
- 2008-09-12 WO PCT/FR2008/001278 patent/WO2009068761A2/fr not_active Ceased
- 2008-09-12 CN CN2008801067270A patent/CN101918000B/zh not_active Expired - Fee Related
- 2008-09-12 MX MX2010002680A patent/MX2010002680A/es active IP Right Grant
- 2008-09-12 BR BRPI0816810A patent/BRPI0816810A2/pt not_active IP Right Cessation
- 2008-09-12 JP JP2010524542A patent/JP5485893B2/ja not_active Expired - Fee Related
- 2008-09-12 CA CA2699590A patent/CA2699590A1/fr not_active Abandoned
- 2008-09-12 ES ES08855583.4T patent/ES2444419T3/es active Active
- 2008-09-12 RU RU2010108505/15A patent/RU2500400C2/ru not_active IP Right Cessation
- 2008-09-12 US US12/675,945 patent/US8431583B2/en not_active Expired - Fee Related
- 2008-09-12 DK DK08855583.4T patent/DK2187889T3/da active
- 2008-09-12 EP EP08855583.4A patent/EP2187889B1/fr not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| ES2444419T3 (es) | 2014-02-25 |
| KR20100075908A (ko) | 2010-07-05 |
| DK2187889T3 (da) | 2014-02-03 |
| BRPI0816810A2 (pt) | 2017-05-16 |
| RU2500400C2 (ru) | 2013-12-10 |
| CA2699590A1 (fr) | 2009-06-04 |
| WO2009068761A3 (fr) | 2010-01-07 |
| RU2010108505A (ru) | 2011-10-20 |
| FR2920776A1 (fr) | 2009-03-13 |
| CN101918000B (zh) | 2012-11-21 |
| EP2187889A2 (fr) | 2010-05-26 |
| CN101918000A (zh) | 2010-12-15 |
| US20100311768A1 (en) | 2010-12-09 |
| EP2187889B1 (fr) | 2013-11-06 |
| JP2010539146A (ja) | 2010-12-16 |
| JP5485893B2 (ja) | 2014-05-07 |
| FR2920776B1 (fr) | 2012-09-28 |
| WO2009068761A2 (fr) | 2009-06-04 |
| US8431583B2 (en) | 2013-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012002134B8 (pt) | compostos inibidores de apaf-1 | |
| MA33939B1 (fr) | 5-alcynyl-pyrimidines | |
| MX353308B (es) | Derivados fosforosos como inhibidores de cinasa. | |
| MX336381B (es) | Boronatos como inhibidores de arginasa. | |
| MX2010009207A (es) | Compuestos y composiciones heterociclicos como inhibidores de c-kit y pdgfr cinasa. | |
| NZ615270A (en) | Phosphoramidate derivatives of 5 - fluoro - 2 ‘ - deoxyuridine for use in the treatment of cancer | |
| NZ595572A (en) | Inhibitors of pi3 kinase and / or mtor | |
| MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
| PH12013501600A1 (en) | Novel heterocyclic derivatives | |
| BR112012008019A2 (pt) | derivados de purina úteis como inibidores de hsp90 | |
| MX2011011733A (es) | Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos. | |
| EA201000098A1 (ru) | Производные хиназолинамида | |
| MX2013001204A (es) | Compuesto para el tratamiento/prevencion de enfermedades inflamatorias oculares. | |
| MX2014012477A (es) | Inhibidores pirrolopirazona de tanquirasa. | |
| MA32505B1 (fr) | 5-alcynyl-pyrimidines | |
| GEP20156346B (en) | Imidazole derivatives as pde10a enzyme inhibitors | |
| JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
| GEP20156315B (en) | Oxazoline and isoxazoline derivatives as crac modulators | |
| MX2010009837A (es) | Tiazolil-dihidro-indazoles. | |
| TN2012000242A1 (en) | Heterocyclic sulfonamide derivatives | |
| BR112013009260A2 (pt) | compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase | |
| TN2011000531A1 (en) | 5- alkynyl - pyridines | |
| MX2010002680A (es) | Uso de derivados de purina para la manufactura de un medicamento. | |
| TN2012000370A1 (en) | 5-alkynyl pyrimidines and their use as kinase inhibitors | |
| TN2011000530A1 (en) | Thia-triaza-cyclopentazulenes as pi3-kinases inhibitors for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |